Skip to main content

Table 3 Clinical 30-day outcome

From: Does the “obesity paradox” exist after transcatheter aortic valve implantation?

Variable

Overall (n = 109)

BMI (kg/m2)

 < 21.9 (n = 27)

21.9–27.0 (n = 55)

 > 27.0 (n = 27)

30-day Mortality

5 (4.6%)

1 (3.7%)

3 (5.5%)

1 (3.7%)

Cerebrovascular accident/transient ischemic attack

3 (2.8%)

1 (3.7%)

1 (1.8%)

1 (3.7%)

Myocardial infarction

2 (1.8%)

0 (0.0%)

1 (1.8%)

1 (3.7%)

Respiratory failure

7 (6.4%)

2 (7.4%)

3 (5.5%)

2 (7.4%)

Cardiogenic shock

3 (2.8%)

1 (3.7%)

2 (3.6%)

0 (0.0%)

Cardiac tamponade

1 (0.9%)

1 (3.7%)

0 (0.0%)

0 (0.0%)

Major bleeding

2 (1.8%)

1 (3.7%)

1 (1.8%)

0 (0.0%)

Major vascular complications

4 (3.7%)

1 (3.7%)

2 (3.6%)

1 (3.7%)

Minor vascular complications

8 (7.3%)

4 (14.8%)

3 (5.5%)

1 (3.7%)

New permanent pacemaker implantation

7 (6.4%)

2 (7.4%)

3 (5.5%)

2 (7.4%)

Acute kidney injury stage 3

13 (11.9%)

4 (14.8%)

7 (12.7%)

2 (7.4%)

New York Heart Association functional class

1.83 ± 0.7

1.81 ± 0.9

1.83 ± 0.9

1.80 ± 0.7

  1. Data are expressed as mean ± standard deviations (SD) or number (%)
  2. Chi-square or Fisher test for categorical variables and t text for continuous variables